Skip to main content


Showing posts from March 14, 2018

Posted in ▶ Canswerist® Today


Marketwired – Mar 1, 2018 – NESS-ZIONA, ISRAEL--(Marketwired - March 01, 2018) - VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative Israeli cancer research company focused on immunotherapy, is pleased to announce that it has successfully obtained a U.S. Patent for its Signal… PDF ▶ ▶ see embedded content below
VAXIL, seems to be an actually mass-produced vaccine (like the polio vaccine), but CART-T is an individually bio-engineered therapy based on a patient's own genetics. More on CART-T ▶ and more on VAXIL @ ▶
Kidney cancer symptoms: A pain in your side could be a sign of deadly disease 
▶ Stem Cells Extend Stroke Treatment Window ▶ NUZZEL ▶ Doctors using glowing dyes to find hidden cancer ▶ NUZZEL ▶ My MCL DX came in April 2006 (age 57 and I will be 70 in June), blastoid type, with a following almost 16 months of various chemo regimens starting with *R-CHOP, then others…